Review article: The modern management of portal vein thrombosis

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 9, 2009, Pages 881-894

  Chawla, Y ^a   Duseja, A ^a   Dhiman, R K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; HEPARIN; STREPTOKINASE; UROKINASE;

ANTICOAGULANT THERAPY; DISEASE ASSOCIATION; FIBRINOLYTIC THERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MESENTERIC VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; SUPERIOR MESENTERIC VEIN; SURGICAL THROMBECTOMY; TREATMENT INDICATION;

ADULT; ANTICOAGULANTS; CARCINOMA, HEPATOCELLULAR; CHILD; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; PORTAL VEIN; THROMBECTOMY; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 70349680740     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04116.x     Document Type: Review

References (151)

1. Sarin SK, Sollano JD, Chawla YK, et al. Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006 26 : 512 519.
2. Ogren M, Bergqvist D, Björck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006 12 : 2115 2119.
3. Denninger MH, Chaït Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000 31 : 587 591.
4. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000 96 : 2364 2368.
5. Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002 70 : 126 132.
6. Bhattacharyya M, Makharia G, Kannan M, et al. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 2004 121 : 844 847.
7. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005 41 : 603 608.
8. Turnes J, García-Pagán JC, González M, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol 2008 6 : 1412 1417.
9. Plessier A, Murad SD, Hernandez Guerra M, et al. A prospective multicentric follow up study on 105 patients with acute portal vein thrombosis: results from EN-VIE. Hepatology 2007 46 (suppl 310A.
10. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999 353 : 1167 1173.
11. Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001 49 : 720 724.
12. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005 43 : 167 176.
13. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007 7 : 34.
14. De Stefano V, Teofili L, Leone G, et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997 23 : 411 418.
15. Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 2005 129 : 553 560.
16. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008 111 : 4922 4929.
17. Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006 130 : 2031 2038.
18. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007 110 : 1092 1097.
19. Valla D, Casadevall N, Huisse MG, et al. Myeloproliferative disorders in portal vein thrombosis in adults. Gastroenterology 1998 94 : 1063 1069.
20. Fisher NC, Wilde JT, Roper J, et al. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 2000 46 : 534 539.
21. De Bruijne EL, Murad SD, de Maat MP, et al. Liver and Thrombosis Study Group. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis. Thromb Haemost 2007 97 : 181 185.
22. Martinelli I, Primignani M, Aghemo A, et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 2009 50 : 916 922.
23. Amitrano L, Guardascione MA, Scaglione M, et al. Acute portal and mesenteric thrombosis: unusual presentation of cytomegalovirus infection. Eur J Gastroenterol Hepatol 2006 18 : 443 445.
24. Amitrano L, Brancaccio V, Guardascione MA, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002 34 : 535 538.
25. Liappis AP, Roberts AD, Schwartz AM, et al. Thrombosis and infection: a case of transient anti-cardiolipin antibody associated with pylephlebitis. Am J Med Sci 2003 325 : 365 368.
26. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001 120 : 490 497.
27. Poultsides GA, Lewis WC, Feld R, et al. Portal vein thrombosis after laparoscopic colectomy: thrombolytic therapy via the superior mesenteric vein. Am Surg 2005 71 : 856 860.
28. Bernades P, Baetz A, Lévy P, et al. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci 1992 37 : 340 346.
29. Fujita F, Lyass S, Otsuka K, et al. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg 2003 69 : 951 956.
30. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992 18 : 353 372.
31. Habu D, Nishiguchi S, Shiomi S, et al. Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma. Indian J Gastroenterol 2002 21 : 162 163.
32. Zheng RQ, Kudo M, Inui K, et al. Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol 2003 38 : 101 103.
33. Matsumoto K, Yamao K, Ohashi K, et al. Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report. Gastrointest Endosc 2003 57 : 269.
34. Langnas AN, Marujo W, Stratta RJ, et al. Vascular complications after orthotopic liver transplantation. Am J Surg 1991 161 : 76 82.
35. Doria C, Marino IR. Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report. Int Surg 2003 88 : 184 187.
36. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004 40 : 736 741.
37. Belli L, Romani F, Sansalone CV, et al. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg 1986 203 : 286 291.
38. Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006 101 : 83 90.
39. Anand AC, Sashindran VK, Mohan L. Gastrointestinal problems at high altitude. Trop Gastroenterol 2006 27 : 147 153.
40. Dörffel T, Wruck T, Rückert RI, et al. Vascular complications in acute pancreatitis assessed by color duplex ultrasonography. Pancreas 2000 21 : 126 133.
41. Yadav S, Dutta AK, Sarin SK. Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr 1993 17 : 392 396.
42. Sakha SH, Rafeey M, Tarzamani MK. Portal venous thrombosis after umbilical vein catheterization. Indian J Gastroenterol 2007 26 : 283 284.
43. Giraudo G, Greget M, Oussoultzoglou E, et al. Preoperative contralateral portal vein embolisation before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 2008 143 : 476 482.
44. Henderson JM, Gilmore GT, Mackay GJ, et al. Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology 1992 16 : 715 718.
45. Ohnishi K, Okuda K, Ohtsuki T, et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. Gastroenterology 1984 87 : 1150 1153.
46. De Gaetano AM, Lafortune M, Patriquin H, et al. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol 1995 165 : 1151 1155.
47. Malkowski P, Pawlak J, Michalowicz B, et al. Thrombolytic treatment of portal thrombosis. Hepatogastroenterology 2003 50 : 2098 2100.
48. Ganguly S, Sarin SK, Bhatia V, Lahoti D. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 1995 21 : 1226 1231.
49. Chawla Y, Dilawari JB. Anorectal varices their frequency in cirrhotic and noncirrhotic portal hypertension. Gut 1991 32 : 309.
50. Chawla Y, Dilawari JB. Gall Bladder varices in portal vein thrombosis. AJR 1994 162 : 643 645.
51. Sarin SK, Bansal A, Sasan S, Nigam A. Portal vein obstruction in children leads to growth retardation. Hepatology 1992 15 : 229 233.
52. de Ville de Goyet J, Alberti D, Falchetti D, et al. Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: a new physiological procedure. Eur J Surg 1999 165 : 777 781.
53. Bellomo-Brandao MA, Morcillo AM, Hessel G, et al. Growth assessment in children with extrahepatic portal vein obstruction and portal hypertension. Ar Gastro 2003 40 : 247 250.
54. Ranjan M, Gupta R, Jain M, Malhotra V, Sarin SK. Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 2003 23 : 434 439.
55. Condat B, Pessine T, Helene DM, Hillaire S, Valla D. Recent portal or mesentric venous thrombosis, increased recognition and frequent recanalisatioon on anticoagulant therapy. Hepatology 2000 32 : 466 470.
56. Minguer B, Farua Papan JC, Bosch J, et al. Non cirrhotic portal vein thrombosis exhibits neuropsychological & MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006 43 : 707 714.
57. Gsoenervey M, Quero JC, DeBraign I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998 28 : 45 9.
58. Dilawari JB, Chawla Y. Pseudoscleoring cholangitis in extrahepatic portal venous obstruction. Gut 1992 33 : 272 276.
59. Khuroo MS, Yattoo GN, Zasyar SA, et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology 1993 17 : 807 813.
60. Dhiman RK, Puri D, Chawla Y, et al. Biliary changes in extrahepatic portal venous obstruction compression by collaterals or ischemia? Gastrointest Endosc 1999 50 : 646 652.
61. Condat B, Vilgram V, Asselak T, et al. Portal carvernoma associated cholangiopathy a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 2003 37 : 1302 1308.
62. Malkhan GH, Bhatia ST, Bastin K, et al. cholangiography associated with portal hypertension diagnostic evaluation and clinical implications. Gastroint Endos 1999 49 : 344 348.
63. Sezgin O, Oguz D, Attritas E, Saritas U, Sahin B. Endoscopic management of biliary obstruction carried by cavernous transformation of portal vein. Gastroint Endos 2003 58 : 602 608.
64. Kobayashi S, Ng CS, Kazama T, et al. Hemodynamic and morphological changes after portal vein embolisation: different efforts central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomog 2004 28 : 804 810.
65. Vilgrain V, Condat B, Bureau C, et al. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology 2006 241 : 149 155.
66. Bilodeau M, Aubry MC, Houle R, et al. Evaluation of hepatocytes injury following partial ligation of the left portal vein. J Hepatol 1999 30 : 29 37.
67. Van Gansbeke D, Avni EF, Delcour C, et al. Sonographic features of portal vein thrombosis. AJR Am J Roentgenol 1985 144 : 749 752.
68. Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int 2005 4 : 515 518.
69. Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol 1991 157 : 293 296.
70. Parvey HR, Eisenberg RL, Giyanani V, et al. Duplex sonography of the portal venous system: pitfalls and limitations. AJR Am J Roentgenol 1989 152 : 765 770.
71. Lai L, Brugge WR. Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST). Am J Gastroenterol 2004 99 : 40 4.
72. Palazzo l, Hochain P, Helmer C, et al. Biliary varieces on endoscopic ultrasonography: clinical presentation ad outcome. Endoscopy 2000 32 : 520 524.
73. Umpheren JL, Pecha RE, Urayama S. Biliary stricture caused by portal bilopathy. Diagnosis by EUS with Doppler US. Gasterintest Endoscopy 2004 60 : 1021 1024.
74. Parvey HR, Raval B, Sandler CM. Portal vein thrombosis: imaging findings. AJR Am J Roentgenol 1994 162 : 77 81.
75. Lee HK, Park SJ, Yi BH, et al. Portal vein thrombosis: CT features. Abdom Imaging 2008 33 : 72 9.
76. Shah TU, Semelka RC, Voultsinos V, et al. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl 2006 12 : 1682 1688.
77. Cakmak O, Elmas N, Tamsel S, et al. Role of contrast-enhanced 3D magnetic resonance portography in evaluating portal venous system compared with color Doppler ultrasonography. Abdom Imaging 2008 33 : 65 71.
78. Smith CS, Sheehy N, McEniff N, et al. Magnetic resonance portal venography: use of fast-acquisition true FISP imaging in the detection of portal vein thrombosis. Clin Radiol 2007 62 : 1180 1188.
79. Lin J, Zhou KR, Chen ZW, et al. Three-dimensional contrast-enhanced MR angiography in diagnosis of portal vein involvement by hepatic tumors. World J Gastroenterol 2003 9 : 1114 1118.
80. Glockner JF, Forauer AR, Solomon H, et al. Three-dimensional gadolinium-enhanced MR angiography of vascular complications after liver transplantation. AJR Am J Roentgenol 2000 174 : 1447 1453.
81. Vlachogiannakos J, Patch D, Watkinson A, et al. Carbon-dioxide portography: an expanding role? Lancet 2000 355 : 987 988.
82. Kreft B, Strunk H, Flacke S, et al. Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology 2000 216 : 86 92.
83. Sun L, Guan YS, Pan WM, et al. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol 2008 14 : 1212 1217.
84. Dilawari JB, Chawla YK, Raju GS, Kaur U, Bambery P. Splenoportovenography in portal hypertension: a safe outpatient procedure. Can Assoc Radiol J 1990 41 : 146 148. (Pubitemid 20202600)
85. Jamieson NV. Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation 2000 69 : 1772 1774.
86. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 2001 345 : 1683 1688.
87. Baril N, Wren S, Radin R, Ralla P, Stain S. The role of anticoagulation in pylephlebitis. Am J Surg 1996 172 : 449 452.
88. Hidajat N, Stobbe H, Griesshaber V, Felix R, Schroder RJ. Imaging and radiological interventions of portal vein thrombosis. Acta Radiol 2005 46 : 336 343.
89. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005 21 : 1 9.
90. Merkel C, Bolognesi M, Bellon S, et al. Long term follow up study of adult patients with noncirrhotis obstruction of the portal system comparison with cirrhotic patients. J Hepatol 1992 15 : 299 303.
91. Chawla YK, Dilawari JB. Portographic changes with time in patients with extrahepatic portal venous obstruction. J Gastroenterol Hepatol 1988 3 : 421 424.
92. Amitrano L, Guardascione MA, Scaglione M, et al. A Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007 102 : 2464 2470.
93. Garcia Pagan JC, Guerra MH, Bosch J. Extrahepatic portal vein thrombosis. Seminars in Liver diseases 2008 28 : 282 292.
94. Dolorich LR, Ginsberg JS, Douketis JD, Holbrook AM, Chealig A. metaanalysis comparing low molecular wt heparin with unfractionated heparin in treatment of venous thrombolism examining some unanswered questions regarding location of treatment product use and dosing frequency. Arch Int Med 2000 160 : 181 188.
95. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005 54 : 691 697.
96. Louvet A, Texier F, Dharancy S, et al. Anticoagulation therapy may sense biliary abnormalities due to acute portal thrombosis. DDS 2006 2006 : 5111 5117.
97. Lopeia JE, Correa G, Brazzini A, et al. Percutaneous, transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002 36 : 1058 1067.
98. Aytekin C, Boyvat F, Kurt A, Yologhuz coskun M. Catheter directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol 2001 39 : 80 2.
99. Hollingshead M, Burke CT, Mauro MA, Weetis SM, Dixon RG, Jaugus PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Inter Radiol 2005 16 : 651 661.
100. Kercher KW, Sing RF, Watson KW, et al. Transhepatic thrombolysis in acute portal vein thrombosis after laproscopic splenectomy. Sung Laproso Endo Percutan Tech 2002 12 : 131 136.
101. Henao EA, Bohamon WT, Silva MB Jr. Treatment of portal vein thrombosis with relative superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vase Surg 2003 38 : 1411 1415.
102. Tateishi A, Mitsui M, Oki T, et al. Extensive mesenteric vein and portal vein thrombosis significantly treated by thromoltis and anticoagulation. J Gastroenterol Hepatol 2001 16 : 1429 1433.
103. Uflacher R. Ajpheat of percutaneous mechanical thromboectomy in TIPS and PVT Tech. Vas Inter Radiol 2003 6 : 59 69.
104. Òuzkurt P, Tercan F, Ince E, Ezer SS, Hiçsönmez A. Percutaneous treatment of portal vein thrombosis in a child who has undergone splenectomy. J Pediatr Surg 2008 43 : e29 32.
105. Ferro C, Rossi CG, Bovio G, Dahamane M, Centenaro M. TIPS mechanical aspiration thembectory and directt thrombolysis in the treatment of acute portal and superior mesenteric vein thrombosis. Cardiovas Intervent Radiol 2007 30 : 1070 1074.
106. Adani GL, Baccarani U, Risaliti A, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Intervent Radiol 2007 30 : 1222 1226.
107. Brearley S, Hawker PC, Dykes PW, Keighley MR. A lethal complication of peripheral vein vasopressin infusion. Hepatogastroenterology 1985 32 : 224 225.
108. Celińska-Cedro D, Teisseyre M, Woynarowski M, et al. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg 2003 38 : 1008 1011. (Pubitemid 36828864)
109. Spaander MC, Murad SD, van Buuren HR, et al. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc 2008 67 : 821 827.
110. Poddar U, Thapa BR, Singh K. Band ligation plus sclerotherapy versussclerotherapy alone in children with extrahepatic portal venous obstruction. J Clin Gastroenterol 2005 39 : 626 629.
111. Dilawari JB, Raju GS, Chawla YK. Development of large spleno-adreno-renal shunt after endoscopic sclerotherapy. Gastroenterology 1989 97 : 421 426.
112. Wolff M, Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg 2003 388 : 141 149.
113. Livingstone AS, Koniaris LG, Perez EA, et al. 507 Warren-Zeppa distal splenorenal shunts: a 34-year experience. Ann Surg 2006 243 : 884 892.
114. Sharma BC, Singh RP, Chawla YK, et al. Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non-cirrhotic portal hypertension. J Gastroenterol Hepatol 1997 12 : 582 584.
115. Dasgupta R, Roberts E, Superina RA, Kim PC. Effectiveness of Rex shunt in the treatment of portal hypertension. J Pediatr Surg 2006 41 : 108 112.
116. Query JA, Sandler AD, Sharp WJ. Use of autogenous saphenous vein as a conduit for mesenterico-left portal vein bypass. J Pediatr Surg 2007 42 : 1137 1140.
117. Krebs-Schmitt D, Briem-Richter A, Grabhorn E, et al. Effectiveness of Rex shunt in children with portal hypertension following liver transplantation or with primary portal hypertension. Pediatr Transplant 2009 13 : 540 544.
118. Kim HB, Pomposelli JJ, Lillehei CW, et al. Mesogonadal shunts for extrahepatic portal vein thrombosis and variceal hemorrhage. Liver Transpl 2005 11 : 1389 1394.
119. Warren WD, Henderson JM, Millikan WJ, et al. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg 1988 207 : 623 634.
120. Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg 2002 194 : 717 728.
121. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006 23 : 767 775.
122. Bilbao JI, Elorz M, Vivas I, et al. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 2004 27 : 474 480.
123. Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol 2006 29 : 785 790.
124. Superina R, Shneider B, Emre S, et al. Surgical guidelines for the management of extra-hepatic portal vein obstruction. Pediatr Transplant 2006 10 : 908 913.
125. Shaw BW Jr., Iwatsuki S, Bron K, et al. Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985 161 : 66 8.
126. Lladó L, Fabregat J, Castellote J, et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant 2007 2 : 716 721.
127. Lendoire J, Raffin G, Cejas N, et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007 9 : 352 356.
128. Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol 2007 13 : 2535 2540.
129. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation : risk factors, screening, management and outcome. Transplantation 2000 69 : 1873 1881.
130. Tao YF, Teng F, Wang ZX, et al. Liver transplant recipients with portal vein thrombosis: a single center retrospective study. Hepatobiliary Pancreat Dis Int 2009 8 : 34 9.
131. Doenecke A, Tsui TY, Zuelke C, et al. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transplant 2009 19, Feb 19, PubMed.
132. Hajdu CH, Murakami T, Diflo T, et al. Intrahepatic portal cavernoma as an indication for liver transplantation. Liver Transpl 2007 13 : 1312 1316.
133. Dhiman RK, Behera A, Chawla YK, et al. Portal hypertensive biliopathy. Gut 2007 56 : 1001 1008.
134. Gauthier-Villars M, Franchi S, Gauthier F, et al. Cholestasis in children with portal vein obstruction. J Pediatr 2005 146 : 568 573.
135. Thervet L, Faulques B, Pissas A, et al. Endoscopic management of obstructive jaundice due to portal cavernoma. Endoscopy 1993 25 : 423 425.
136. Bhatia V, Jain AK, Sarin SK. Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc 1995 42 : 178 181.
137. Tighe M, Jacobson I. Bleeding from bile duct varices: an unexpected hazard during therapeutic ERCP. Gastrointest Endosc 1996 43 : 250 252.
138. Mutignani M, Shah SK, Bruni A, et al. Endoscopic treatment of extrahepatic bile duct strictures in patients with portal biliopathy carries a high risk of haemobilia: report of 3 cases. Dig Liver Dis 2002 34 : 587 591.
139. Chaudhary A, Dhar P, Sarin SK, et al. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg 1998 85 : 326 329.
140. Vibert E, Azoulay D, Aloia T, et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg 2007 246 : 97 104.
141. Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005 17 : 745 751.
142. Connolly GC, Chen R, Hyrien O, et al. Incidence, risk factors and consequences of portal vein and systemic thrombosesin hepatocellular carcinoma. Thromb Res 2008 122 : 299 306.
143. D'Amico M, Pasta L, Sammarco P. MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis. J Thromb Thrombolysis 2008 28 : 70 3.
144. Carr BI, Buch SC, Kondragunta V, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study. J Gastroenterol Hepatol 2008 23 : 1259 1266.
145. Rossi S, Rosa L, Ravetta V, et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol 2006 186 : 763 773.
146. Rossi S, Ghittoni G, Ravetta V, et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol 2008 18 : 1749 1756.
147. Neeman Z, Libutti SK, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging 2003 27 : 417 420.
148. Salem R, Lewandowski R, Roberts C, et al. Use of Yttrium-90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004 15 : 335 345.
149. Kulik LM, Carr BI, Mulcahy MF, et al. Safety and efficacy of 90 Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008 47 : 71 81.
150. Sotiropoulos GC, Radtke A, Schmitz KJ, et al. Liver transplantation in the setting of hepatocellular carcinoma and portal vein thrombosis: a challenging dilemma? Dig Dis Sci 2008 53 : 1994 1999.
151. Huang YJ, Hsu HC, Wang CY, et al. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009 73 : 1155 1163.